Company Quick10K Filing
Celgene
10-Q 2019-09-30 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-07-30
10-Q 2019-03-31 Filed 2019-04-25
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-10-25
10-Q 2018-06-30 Filed 2018-07-26
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-02-07
10-Q 2017-09-30 Filed 2017-10-26
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-10-27
10-Q 2016-06-30 Filed 2016-07-28
10-Q 2016-03-31 Filed 2016-05-03
10-K 2015-12-31 Filed 2016-02-11
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-07-28
10-Q 2015-03-31 Filed 2015-04-30
10-K 2014-12-31 Filed 2015-02-20
10-Q 2014-09-30 Filed 2014-10-28
10-Q 2014-06-30 Filed 2014-07-29
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-10-29
10-Q 2013-06-30 Filed 2013-07-30
10-Q 2013-03-31 Filed 2013-04-30
10-K 2012-12-31 Filed 2013-02-15
10-Q 2012-09-30 Filed 2012-10-29
10-Q 2012-06-30 Filed 2012-08-01
10-Q 2012-03-31 Filed 2012-05-02
10-K 2011-12-31 Filed 2012-02-22
10-Q 2011-09-30 Filed 2011-11-02
10-Q 2011-06-30 Filed 2011-08-03
10-Q 2011-03-31 Filed 2011-05-05
10-K 2010-12-31 Filed 2011-03-01
10-Q 2010-09-30 Filed 2010-11-02
10-Q 2010-06-30 Filed 2010-08-04
10-Q 2010-03-31 Filed 2010-05-03
10-K 2009-12-31 Filed 2010-02-18
8-K 2019-11-21
8-K 2019-11-15
8-K 2019-10-31
8-K 2019-08-25
8-K 2019-07-30
8-K 2019-04-25
8-K 2019-04-12
8-K 2019-04-04
8-K 2019-03-29
8-K 2019-03-25
8-K 2019-03-08
8-K 2019-01-31
8-K 2019-01-07
8-K 2019-01-03
8-K 2019-01-02
8-K 2018-11-01
8-K 2018-10-25
8-K 2018-07-26
8-K 2018-07-09
8-K 2018-06-29
8-K 2018-06-28
8-K 2018-06-19
8-K 2018-06-13
8-K 2018-05-31
8-K 2018-05-30
8-K 2018-05-24
8-K 2018-05-04
8-K 2018-04-25
8-K 2018-04-17
8-K 2018-04-02
8-K 2018-03-06
8-K 2018-02-26
8-K 2018-02-20
8-K 2018-02-14
8-K 2018-02-13
8-K 2018-02-08
8-K 2018-02-08
8-K 2018-02-06
8-K 2018-02-02
8-K 2018-01-26
8-K 2018-01-25
8-K 2018-01-25
8-K 2018-01-22
8-K 2018-01-21
8-K 2018-01-08
8-K 2018-01-07

Celgene Financials

CELG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
AbbVie (ABBV) 109,786 77% 21.1 5% 59,441 67,667 32,867 25,412 3,255 6,259 132,264
Eli Lilly (LLY) 105,897 78% 12.7 21% 37,893 34,431 22,644 17,612 7,948 9,419 119,560
Beigene (BGNE) 100,124 74% -123.1 -44% 1,881 587 430 318 -827 -807 99,328
Bristol Myers Squibb (BMY) 82,160 70% 10.6 10% 57,433 39,679 24,173 16,837 5,680 7,151 76,061
Celgene (CELG) 72,111 96% 10.4 14% 41,363 29,276 16,982 16,354 5,880 7,734 80,796
Zoetis (ZTS) 60,799 51% 29.1 13% 11,272 8,594 6,150 3,124 1,461 2,252 65,484
Allergan (AGN) 54,957 63% -241.2 -5% 122,925 38,486 15,818 9,949 -5,872 -316 76,270
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
GW Pharmaceuticals (GWPH) 45,954 89% -870.1 -8% 848 128 205 182 -64 -52 45,400
Vertex Pharmaceuticals (VRTX) 43,431 87% 46.7 29% 7,515 2,261 3,620 3,135 2,144 857 40,027
Regeneron Pharmaceuticals (REGN) 32,266 0% 12.2 15% 13,939 3,435 7,622 0 2,144 2,539 30,869
Alexion Pharmaceuticals (ALXN) 23,581 92% 12.8 10% 14,815 4,448 4,736 4,359 1,470 1,874 23,912
Biomarin Pharmaceutical (BMRN) 12,700 79% 1,194.1 -1% 4,558 1,484 1,250 986 -39 11 13,147
Mylan (MYL) 10,768 34% 12.5 -0% 31,054 19,590 8,309 2,810 -4 1,882 23,458
Elanco Animal Health (ELAN) 9,964 52% 30.6 1% 8,824 3,336 3,083 1,611 94 393 12,004
Alnylam Pharmaceuticals (ALNY) 8,913 80% -9.7 -32% 2,542 935 169 135 -821 -820 7,987
Ionis Pharmaceuticals (IONS) 8,784 76% 17.4 15% 2,895 1,397 821 626 436 491 8,536
Bausch (BHC) 7,760 0% 25.3 -1% 31,667 29,107 8,498 0 -266 1,216 30,774
Jazz Pharmaceuticals (JAZZ) 7,549 21% 11.2 11% 5,528 2,473 2,056 441 609 762 8,530
Perrigo (PRGO) 7,421 37% 17.9 2% 11,311 5,552 4,710 1,735 247 580 10,388

Balance Sheet ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,1021,0568562,8321,3511,4871,6481,7951,8591,8611,8622,7162,0901,4961,7422,4233,2342,3973,2203,7424,1224,3684,5316,0164,8804,4465,0645,5236,1705,2736,6605,5117,0132,8191,5032,4804,2345,4337,2149,604
Accounts Receivable4394814775937068048638889461,0358859579611,0291,0141,0931,0611,0721,1241,0681,1671,1791,2731,2721,4211,4201,5151,5861,6211,6141,7291,8161,9211,9912,0642,1202,0662,3272,4512,374
Inventory101102101109260223196188190216223236259275294313340348360372393387414421443471490508498509533537541536555510458442464451
PP&E2983043093196985174734907665195275479195785855921,0265966056241,1666506757021,4468408548911,6479589891,0021,9031,2511,2921,3132,3601,3831,4001,415
Assets5,3895,9866,1786,55510,1779,84410,0529,76310,00610,34810,38111,60911,73411,45311,96413,62913,37812,70415,60216,40317,34017,48017,74627,36927,05325,96426,56226,75428,08628,82030,30631,73630,14134,55633,44434,21535,48037,63939,18341,363
Accounts Payable37676750949910098122100109110146117142140156149184197198204205189241220230235247240272263305320294292418340327421
Long-Term Debt1,2481,2471,2601,3161,2941,2961,3182,8662,8932,8682,7554,2524,2694,3566,7436,7376,9886,3036,25614,29814,29914,26814,31213,80214,57213,78413,78312,87416,60020,27119,75419,74219,76919,78119,79018,289
Liabilities9951,2211,2501,4094,1823,9664,0574,1584,4934,2704,4235,8806,0405,8986,5577,7347,7888,22010,75110,63510,81510,71611,42421,99421,13420,88921,01321,10321,48621,17621,86121,88623,22029,38430,01429,35529,31929,47429,13229,276
Stockholders' Equity4,3954,7644,9285,1465,9845,8685,9955,6055,5136,0785,9585,7295,6945,5545,4075,8955,5904,4854,8515,7686,5256,7656,3225,3765,9195,0755,5495,6506,5997,6448,4459,8506,9215,1723,4304,8606,1618,16510,05112,087
Income Statement ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue7918539101,0721,1251,3981,2501,2841,2731,3671,4191,4471,4651,5991,6741,7561,7301,8731,9822,0862,0812,2782,3342,5632,5122,7542,9832,9802,9603,2683,2873,4833,5383,8143,8924,0374,0254,4004,520
Cost of Revenue626864113127190119112124134130117123126157170140151167
Gross Profit7297858479279981,2081,1651,3351,6321,9522,4342,8633,3603,6883,7353,8673,8854,2494,353
R&D20534325404355533574363624474424734524585847317144576755855061,1101,3047777339491,6541,1359958351,3472,7382,2031,2511,0811,2161,1001,167
SG&A208219228295302380303315326323355370369432449449494537498544529617550609543732698685620939608774864790746773793781
Tax544349133339401485871971007780713971096997108115141841219785701282051171,21238739929644275250226
Net Income234155281210256279373410402367424263385478372214280598508614719356-345618015981714299411,061988-818461,0451,0821,0731,5451,5711,691
Cash Flow ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating2853103822052754614703116375814903677375715515575169018338562842859759367221,3438531,6161,0881,689-3251,2291,9241,4762,1672,172
Cash Investing-364-4131,573-2,904276-10666-6-344-428-775-252-275-916915-220-986-159-73338-98-6,138-110-75-112-704-1,66045-2,3741,098-5,658-128-31-295-43137
Cash Financing44-8841,217-427-197-457-310-282749-405-687-2121,003-657-1,1681,278-176-352-908-437,349-1,320-223-15653-109-315132-1,2921,756-2,399-91326-347102